NO20032818D0 - Polypeptider - Google Patents

Polypeptider

Info

Publication number
NO20032818D0
NO20032818D0 NO20032818A NO20032818A NO20032818D0 NO 20032818 D0 NO20032818 D0 NO 20032818D0 NO 20032818 A NO20032818 A NO 20032818A NO 20032818 A NO20032818 A NO 20032818A NO 20032818 D0 NO20032818 D0 NO 20032818D0
Authority
NO
Norway
Prior art keywords
polypeptides
cancer
recognising
eliciting
prophylaxis
Prior art date
Application number
NO20032818A
Other languages
English (en)
Other versions
NO332137B1 (no
NO20032818L (no
Inventor
Gustav Gaudernack
Stein Saeboee-Larssen
Mona Moeller
Jon Amund Eriksen
Original Assignee
Gemvax As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=9905720&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO20032818(D0) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Gemvax As filed Critical Gemvax As
Priority to NO20032818A priority Critical patent/NO332137B1/no
Publication of NO20032818D0 publication Critical patent/NO20032818D0/no
Publication of NO20032818L publication Critical patent/NO20032818L/no
Publication of NO332137B1 publication Critical patent/NO332137B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10—Transferases (2.)
    • C12N9/12—Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/47—Hydrolases (3) acting on glycosyl compounds (3.2), e.g. cellulases, lactases
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/40—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against enzymes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10—Transferases (2.)
    • C12N9/12—Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
    • C12N9/1241—Nucleotidyltransferases (2.7.7)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Public Health (AREA)
  • Biochemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Immunology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Medicinal Preparation (AREA)
NO20032818A 2000-12-22 2003-06-19 Polypeptid, nukleinsyre, T-lymfocytt og vektor for anvendelse innen medisin samt farmasoytisk sammensetning omfattende nevnte polypeptid. NO332137B1 (no)

Priority Applications (1)

Application Number Priority Date Filing Date Title
NO20032818A NO332137B1 (no) 2000-12-22 2003-06-19 Polypeptid, nukleinsyre, T-lymfocytt og vektor for anvendelse innen medisin samt farmasoytisk sammensetning omfattende nevnte polypeptid.

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB0031430.2A GB0031430D0 (en) 2000-12-22 2000-12-22 Polypeptides
PCT/NO2001/000498 WO2002051994A2 (en) 2000-12-22 2001-12-18 Polypeptides
NO20032818A NO332137B1 (no) 2000-12-22 2003-06-19 Polypeptid, nukleinsyre, T-lymfocytt og vektor for anvendelse innen medisin samt farmasoytisk sammensetning omfattende nevnte polypeptid.

Publications (3)

Publication Number Publication Date
NO20032818D0 true NO20032818D0 (no) 2003-06-19
NO20032818L NO20032818L (no) 2003-08-21
NO332137B1 NO332137B1 (no) 2012-07-02

Family

ID=9905720

Family Applications (2)

Application Number Title Priority Date Filing Date
NO20032818A NO332137B1 (no) 2000-12-22 2003-06-19 Polypeptid, nukleinsyre, T-lymfocytt og vektor for anvendelse innen medisin samt farmasoytisk sammensetning omfattende nevnte polypeptid.
NO20110429A NO342257B1 (no) 2000-12-22 2011-03-21 Polypeptider, nukleinsyre-DNA og vektorer for anvendelse som et medikament i behandling av cancer

Family Applications After (1)

Application Number Title Priority Date Filing Date
NO20110429A NO342257B1 (no) 2000-12-22 2011-03-21 Polypeptider, nukleinsyre-DNA og vektorer for anvendelse som et medikament i behandling av cancer

Country Status (14)

Country Link
US (4) US7078416B2 (no)
EP (3) EP2361978B1 (no)
JP (3) JP2004522433A (no)
AT (2) ATE550426T1 (no)
AU (3) AU2002216477B2 (no)
CA (2) CA2432971C (no)
CY (2) CY1106564T1 (no)
DE (1) DE60127715T2 (no)
DK (3) DK2361978T3 (no)
ES (2) ES2382821T3 (no)
GB (1) GB0031430D0 (no)
NO (2) NO332137B1 (no)
PT (2) PT1862544E (no)
WO (1) WO2002051994A2 (no)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NO315238B1 (no) * 1998-05-08 2003-08-04 Gemvax As Peptider som stammer fra leserammeforskyvingsmutasjoner i TBF<beta>II- eller BAX-genet, og farmasöytiske sammensetninger inneholdende disse,nukleinsyresekvenser som koder for slike peptider, plasmider og virusvektoreromfattende slikenukleinsy
AU2001241533A1 (en) * 2000-02-15 2001-08-27 The Regents Of The University Of California A universal vaccine and method for treating cancer employing telomerase reverse transcriptase
GB0031430D0 (en) * 2000-12-22 2001-02-07 Norsk Hydro As Polypeptides
KR101164509B1 (ko) * 2002-12-16 2012-07-10 글로브이뮨 면역 요법으로서의 효모계 백신
US8343502B2 (en) * 2002-12-16 2013-01-01 Globeimmune, Inc. Yeast-based vaccines as immunotherapy
US7439042B2 (en) * 2002-12-16 2008-10-21 Globeimmune, Inc. Yeast-based therapeutic for chronic hepatitis C infection
EP2463299A3 (en) 2003-03-05 2012-10-17 Dendreon Corporation Compositions and methods employing alternative reading frame polypeptides for the treatment of cancer and infectious disease
CN101437964B (zh) 2004-10-18 2012-06-13 全球免疫股份有限公司 基于酵母的对慢性丙型肝炎感染的治疗
US9732131B2 (en) 2006-02-27 2017-08-15 Calviri, Inc. Identification and use of novopeptides for the treatment of cancer
EP2331125A4 (en) 2008-09-19 2013-03-27 Globeimmune Inc IMMUNOTHERAPY FOR CHRONIC HEPATITIS C-VIRUS INFECTIONS
GB0821616D0 (en) 2008-11-26 2008-12-31 Lytix Biopharma As Compounds
CN110709094A (zh) 2017-02-03 2020-01-17 威斯康星州医药大学股份有限公司 Kras肽疫苗组合物及其使用方法
EP3630131B1 (en) 2017-06-02 2022-08-31 Arizona Board of Regents on behalf of Arizona State University A method to create personalized canine cancer vaccines
US20200209241A1 (en) 2017-09-15 2020-07-02 Arizona Board Of Regents On Behalf Of Arizona State University Methods of classifying response to immunotherapy for cancer
WO2021067550A1 (en) 2019-10-02 2021-04-08 Arizona Board Of Regents On Behalf Of Arizona State University Methods and compositions for identifying neoantigens for use in treating and preventing cancer

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4803070A (en) 1986-04-15 1989-02-07 Ribi Immunochem Research Inc. Immunological emulsion adjuvants for polysaccharide vaccines
GB9103974D0 (en) 1991-02-26 1991-04-10 Norsk Hydro As Therapeutically useful peptides or peptide fragments
CA2294782A1 (en) * 1997-07-01 1999-01-14 Cambia Biosystems Llc Vertebrate telomerase genes and proteins and uses thereof
US6337200B1 (en) * 1998-03-31 2002-01-08 Geron Corporation Human telomerase catalytic subunit variants
JP2002509716A (ja) 1998-03-31 2002-04-02 ユニバーシティ テクノロジー コーポレイション テロメラーゼ抗原に対する免疫応答を惹起するための方法および組成物
US6362784B1 (en) * 1998-03-31 2002-03-26 Matsuda Electric Industrial Co., Ltd. Antenna unit and digital television receiver
NO315238B1 (no) 1998-05-08 2003-08-04 Gemvax As Peptider som stammer fra leserammeforskyvingsmutasjoner i TBF<beta>II- eller BAX-genet, og farmasöytiske sammensetninger inneholdende disse,nukleinsyresekvenser som koder for slike peptider, plasmider og virusvektoreromfattende slikenukleinsy
US7030211B1 (en) 1998-07-08 2006-04-18 Gemvax As Antigenic peptides derived from telomerase
JP2002541811A (ja) 1999-04-09 2002-12-10 バイオミラ，インコーポレイテッド テロメラーゼ特異的癌ワクチン
WO2000073801A2 (en) 1999-05-28 2000-12-07 Ludwig Institute For Cancer Research Breast, gastric and prostate cancer associated antigens and uses therefor
GB0031430D0 (en) * 2000-12-22 2001-02-07 Norsk Hydro As Polypeptides

Also Published As

Publication number Publication date
US20120269858A1 (en) 2012-10-25
US8193326B2 (en) 2012-06-05
GB0031430D0 (en) 2001-02-07
JP2012080883A (ja) 2012-04-26
ES2280311T3 (es) 2007-09-16
ES2382821T3 (es) 2012-06-13
EP2361978B1 (en) 2015-10-14
JP2014138587A (ja) 2014-07-31
JP2004522433A (ja) 2004-07-29
WO2002051994A2 (en) 2002-07-04
PT1862544E (pt) 2012-05-07
NO332137B1 (no) 2012-07-02
AU2007211889B2 (en) 2009-11-19
AU2007211889B8 (en) 2009-12-10
US20080187551A1 (en) 2008-08-07
ATE550426T1 (de) 2012-04-15
AU2007211889A1 (en) 2007-09-13
EP1862544B2 (en) 2016-03-09
EP1862544A1 (en) 2007-12-05
US20040072759A1 (en) 2004-04-15
US7375117B2 (en) 2008-05-20
AU2002216477B2 (en) 2007-05-24
DE60127715T2 (de) 2007-12-27
NO20110429L (no) 2003-08-21
EP1862544B1 (en) 2012-03-21
CY1112735T1 (el) 2016-02-10
EP1352056A2 (en) 2003-10-15
US7078416B2 (en) 2006-07-18
US20060194731A1 (en) 2006-08-31
CY1106564T1 (el) 2012-01-25
DK2361978T3 (en) 2016-01-25
DK1862544T3 (da) 2012-07-09
EP2361978A1 (en) 2011-08-31
NO20032818L (no) 2003-08-21
ATE358716T1 (de) 2007-04-15
WO2002051994A3 (en) 2002-12-27
PT1352056E (pt) 2007-05-31
CA2782510C (en) 2014-07-15
AU2010200620B2 (en) 2012-11-01
CA2432971A1 (en) 2002-07-04
AU2010200620A1 (en) 2010-03-11
AU2002216477C1 (en) 2002-07-08
EP1352056B1 (en) 2007-04-04
DK1352056T3 (da) 2007-05-29
DE60127715D1 (de) 2007-05-16
CA2432971C (en) 2012-09-04
AU2007211889C1 (en) 2010-06-10
WO2002051994A8 (en) 2003-03-06
CA2782510A1 (en) 2002-07-04
NO342257B1 (no) 2018-04-30

Similar Documents

Publication Publication Date Title
NO20110429L (no) Polypeptider og nukleinsyre-DNA for anvendelse innen medisin
CY1118443T1 (el) Anti-tnf αντισωματα, συνθεσεις, μεθοδοι και χρησεις
CY1117786T1 (el) Διαφορικα εκφραζομενα σε ογκους γονιδιακα προϊοντα και χρηση αυτων
DK1005540T3 (da) IKK-beta-proteiner, nukleinsyrer og fremgangsmåder
CY1113421T1 (el) Πυρηνικα οξεα και πολυπεπτιδια υποδοχεα
CY1113379T1 (el) Πεπτιδια κdr και εμβολια που τα περιλαμβανουν
DE69435075D1 (de) , die signalsequenzpeptide des endoplasmatischen reticulums und mindestens ein anderes peptid codieren, deren verwendung in impfstoffen und zur behandlung von krankheiten
IL153996A0 (en) Polypeptides containing at least a portion of an ovarian carcinoma protein, polynucleotides encoding the same and pharmaceutical compositions containing the same
HUP0300369A2 (hu) Többértékű antitestek és alkalmazásuk
AU2003242305A1 (en) Hla-a24-restricted cancer antigen peptide
TR200102191T2 (tr) HER-2/neu füzyon proteinleri.
AR006250A1 (es) Compuestos y metodos para la inmunoterapia e inmunodiagnostico del cancer prostatico
CY1106806T1 (el) Dna και πολυπεπτιδια ανθρωπινης tslp
ATE418563T1 (de) Nik proteine, nukleinsäure sowie verfahren
TR200700740T2 (tr) Nogo genlerinin nükleotid ve protein dizileri ve bunlar bazında yöntemler
NO944245L (no) Rekombinante DNA-molekyler som koder for aminopeptidase-enzymer og deres anvendelse ved fremstilling av vaksiner mot helmintinfeksjoner
ATE307889T1 (de) Agarase und gen dafür
DK1536006T3 (da) Cancerantigener og anvendelse deraf
RS20050577A (en) Compositions and methods for treating cancer using igsf9 and liv-1
BR0113099A (pt) Gene e proteìna relacionados com esquizofrenia
WO2003093298A3 (en) Immunogenic peptides
AU2003234342A8 (en) Ablated slam-dependent entry
FR2813606B1 (fr) Proteine bard1 tronquee, et ses applications diagnostiques et therapeutiques
TH55539B (th) เพปไทด์ที่เป็นแอนติเจน

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees